Incorporation of FcRn‐mediated disposition model to describe the population pharmacokinetics of therapeutics monoclonal IgG antibody in clinical patients

CONCLUSIONThis first reported semi‐mechanistic model may serve as important model framework for developing future population PK model of TMAbs in clinical patients. This article is protected by copyright. All rights reserved.
Source: Biopharmaceutics and Drug Disposition - Category: Drugs & Pharmacology Authors: Tags: Special Issue Article Source Type: research